Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 2/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | USP1 | O94782 | 1/20 | 0.31 |
| ▸ | WDR48 | Q8TAF3 | 1/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21021507 | 0.89 | ABCG2 (0.37) | ABCG2KIF11KDM4EALDH1A1GAA | |
| SCHEMBL20650456 | 0.85 | SLC22A12 (0.33) | SLC22A12KIF11HDAC6HDAC1USP1 | |
| SCHEMBL21020604 | 0.85 | HDAC6 (0.34) | KIF11HDAC6HDAC1NR1H3 | |
| SCHEMBL21020601 | 0.85 | NR1H2 (0.33) | HDAC6HDAC1NR1H3 | |
| SCHEMBL21020478 | 0.85 | ENPP1 (0.33) | HDAC6HDAC1ALDH1A1 | |
| SCHEMBL21020479 | 0.84 | ACP1 (0.36) | KIF11HDAC6HDAC1NR1H3ALDH1A1 | |
| SCHEMBL21020330 | 0.84 | ABCG2 (0.38) | ABCG2KDM4EALDH1A1GAAMAPT | |
| SCHEMBL21020603 | 0.82 | ACP1 (0.32) | HDAC6 | |
| SCHEMBL21020593 | 0.82 | KDM4E (0.39) | ABCG2HDAC6KDM4EALDH1A1GAA | |
| SCHEMBL21021501 | 0.82 | ABCG2 (0.39) | ABCG2KDM4EALDH1A1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | ABCG2 1596/4885SLC22A12 643/4885KIF11 1480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.